Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 44, 2016 - Issue 8
Submit an article Journal homepage
880
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance

Bin YuDepartment of Urology, Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, China
,
Hongzhou CaiDepartment of Urology, Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, China
,
Zicheng XuDepartment of Urology, Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, China
,
Ting XuDepartment of Urology, Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, China
,
Qing ZouDepartment of Urology, Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, China
&
Min GuDepartment of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
Pages 1818-1823 | Received 25 Aug 2015, Accepted 02 Oct 2015, Published online: 02 Dec 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Taotao Zhang, Wanshuang Cao, Hongliang Sun, Dexin Yu & Caiyun Zhong. (2023) Diallyl Trisulfide Suppresses the Renal Cancer Stem-like Cell Properties via Nanog. Nutrition and Cancer 75:3, pages 971-979.
Read now
Zhigang Qin, Xin Wei, Ning Jin, Yao Wang, Rui Zhao, Yangqing Hu, Weijian Yan, Junke Li & Qiaoling Zhou. (2018) MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1920-1925.
Read now
Fan Yang, Jiaming Zhang & Hua Yang. (2018) OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients. OncoTargets and Therapy 11, pages 7873-7881.
Read now

Articles from other publishers (13)

Deepika Singh, Dipanjan Biswas, Mallika Tewari, Amrita Ghosh Kar, Mumtaz Ahmad Ansari, Sunita Singh & Gopeshwar Narayan. (2023) Clinical Significance of Overexpression of Oct4 in Advanced Stage Gallbladder Carcinoma. Journal of Gastrointestinal Cancer.
Crossref
Yingqing Liu, Jiawei Wang, Lin Li, Haibo Qin, Yuang Wei, Xu Zhang, Xiaohan Ren, Wei Ding, Xudong Shen, Guangyao Li, Zhongwen Lu, Dong Zhang, Chao Qin, Lingsong Tao & Xinglin Chen. (2022) AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma. Scientific Reports 12:1.
Crossref
Constanza Thaise Xavier Silva, Vera Aparecida Saddi, Kleber Santiago Freitas e Silva, Denis Masashi Sugita & Lidia Andreu Guillo. (2021) Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma. Melanoma Research 31:5, pages 439-448.
Crossref
Zahra Hosseini-khah, Mohammad Reza Babaei, Mohsen Tehrani, Magali Cucchiarini, Henning Madry, Abolghasem Ajami, Nasser Rakhshani, Alireza Rafiei & Behrooz Nikbin. (2021) SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology 28:4, pages 3015-3029.
Crossref
Saetbyul Kim, Eunyeong Bok, Sangyeob Lee, Hyeon-Jeong Lee, Yongho Choe, Na-Hyun Kim, Won-Jae Lee, Gyu-Jin Rho & Sung-Lim Lee. (2021) Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors. Journal of Veterinary Science 22:5.
Crossref
Rosa Jahangiri, Fatemeh Mosaffa, Amirnader EmamiRazavi, Masoumeh Gharib & Khadijeh Jamialahmadi. (2019) Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients. Pathology & Oncology Research 26:3, pages 1921-1934.
Crossref
Pengchao Fang, Liuting Zhou, Lee Y. Lim, Hualin Fu, Zhi-xiang Yuan & Juchun Lin. (2020) Targeting Strategies for Renal Cancer Stem Cell Therapy. Current Pharmaceutical Design 26:17, pages 1964-1978.
Crossref
Gašper Grubelnik, Emanuela Boštjančič, Ana Pavlič, Marina Kos & Nina Zidar. (2020) NANOG expression in human development and cancerogenesis. Experimental Biology and Medicine 245:5, pages 456-464.
Crossref
Xiaoyan Zhao, Hui Lu, Yan Sun, Li Liu & Huafang Wang. (2020) Prognostic value of octamer binding transcription factor 4 for patients with solid tumors. Medicine 99:42, pages e22804.
Crossref
Yu-Wei Chang & Kamaleshwar P. Singh. (2019) Arsenic-Induced Neoplastic Transformation Involves Epithelial–Mesenchymal Transition and Activation of the β-Catenin/c-Myc Pathway in Human Kidney Epithelial Cells. Chemical Research in Toxicology 32:6, pages 1299-1309.
Crossref
Jingcheng Zhou, Jiangyi Wang, Baoan Hong, Kaifang Ma, Haibiao Xie, Lei Li, Kenan Zhang, Bowen Zhou, Lin Cai & Kan Gong. (2019) Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma – a retrospective study using TCGA database. Aging 11:6, pages 1633-1647.
Crossref
Arezoo Rasti, Mitra Mehrazma, Zahra Madjd, Maryam Abolhasani, Leili Saeednejad Zanjani & Mojgan Asgari. (2018) Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas. Scientific Reports 8:1.
Crossref
Liuping You, Xin GuoYuenan Huang. (2018) Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer. Yonsei Medical Journal 59:1, pages 35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.